Get started
Author

Amber de Vos

PB2098 Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: cost-effectiveness analysis of the DosEmi study
2026 · Diaz Prameyllawati, Amber de Vos, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
PB2340 The occurrence of intracranial bleeds following a rollercoaster ride in the general population: a literature overview
2026 · Amber de Vos, Corien Eckhardt · Research and Practice in Thrombosis and Haemostasis
PDF
PB2288 The influence of stress-inducing virtual reality content on stress-related coagulation factors in healthy participants – the 8baan study
2026 · Amber de Vos, Larissa Blom, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
PB2279 Pain during emicizumab administration is significant in people with hemophilia A
2026 · Amber de Vos, Konrad van der Zwet, et al. · Research and Practice in Thrombosis and Haemostasis
Incorporating angina into the H 2 FPEF score improves diagnostic performance for HFpEF in women
2026 · Kaiyong Qu, N. Charlotte Onland-Moret, et al. · Open Heart
Works count: 5
Citation count:
H-index:
I10-index:
Year
Topic
Type